●founderChinese labs are well-capitalized and price-aggressive; if you're building on top of frontier models, the competitive set now includes heavily funded Chinese alternatives.
●investorThree rounds in six months at escalating valuations suggests Chinese frontier model investment hasn't cooled despite margin compression — watch for whether this capital translates to capability gains.